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Abstract
Background: Numerous neurological and psychiatric disorders show sex differences in incidence, age of onset,
symptomatology or outcome. Astrocytes, one of the glial cell types of the brain, show sex differences in number,
differentiation and function. Since astrocytes are involved in the response of neural tissue to injury and
inflammation, these cells may participate in the generation of sex differences in the response of the brain to
pathological insults. To explore this hypothesis, we have examined whether male and female astrocytes show a
different response to an inflammatory challenge and whether perinatal testosterone influences this response.
Methods: Cortical astrocyte cultures were prepared from postnatal day 1 (one day after birth) male or female CD1
mice pups. In addition, cortical astrocyte cultures were also prepared from female pups that were injected at birth
with 100 μg of testosterone propionate or vehicle. Cultures were treated for 5 hours with medium containing
lipopolysaccharide (LPS) or with control medium. The mRNA levels of IL6, interferon-inducible protein 10 (IP10),
TNFa, IL1b, Toll-like receptor 4 (TLR4), steroidogenic acute regulatory protein and translocator protein were
assessed by quantitative real-time polymerase chain reaction. Statistical significance was assessed by unpaired t-test
or by one-way analysis of variance followed by the Tukey post hoc test.
Results: The mRNA levels of IL6, TNFa and IL1b after LPS treatment were significantly higher in astrocytes derived
from male or androgenized females compared to astrocytes derived from control or vehicle-injected females. In
contrast, IP10 mRNA levels after LPS treatment were higher in astrocytes derived from control or vehicle-injected
females than in those obtained from males or androgenized females. The different response of male and female
astrocytes to LPS was due neither to differences in the basal expression of the inflammatory molecules nor to
differences in the expression of the LPS receptor TLR4. In contrast, the different inflammatory response was
associated with increased mRNA levels of translocator protein, a key steroidogenic regulator, in female astrocytes
that were treated with LPS.
Conclusions: Male and female cortical astrocytes respond differentially to an inflammatory challenge and this may
be predetermined by perinatal testosterone exposure.
Keywords: IFN-inducible protein 10, IL1β, IL6, steroidogenic acute regulatory protein, testosterone, Toll-like receptor
4, translocator protein 18 kDa, TNFα
Background
Astrocytes, one of the glial cell types of the central nervous
system (CNS), are involved in a variety of functions under
physiological conditions, including the control of brain
blood flow and neuronal metabolism [1,2]. In addition,
astrocytes regulate extracellular potassium levels and
neuronal excitability and, by means of astrocyte-astrocyte
and astrocyte-neuron communication, participate in the
regulation of synaptic transmission, synaptic plasticity and
information processing in the CNS [3,4]. Astrocytes also
play an important role under pathological conditions.
Together with microglia, these cells participate in the local
inflammatory response of the CNS, releasing a variety of
inflammatory mediators, including cytokines, such as IL6,
TNFa and IL1b, and chemokines, such as IFN-inducible
protein 10 (IP10) [5-7]. Astrocytes also express Toll-like
receptor 4 (TLR4), which mediates the inflammatory
actions of lipopolysaccharide (LPS) in these cells [8-12].* Correspondence: lmgs@cajal.csic.es
Instituto Cajal, CSIC, Avenida Doctor Arce 37, E-28002 Madrid, Spain
Santos-Galindo et al. Biology of Sex Differences 2011, 2:7
http://www.bsd-journal.com/content/2/1/7
© 2011 Santos-Galindo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Sex differences in the number, differentiation and func-
tion of astrocytes [13-24] are associated in several CNS
regions with sex differences in the structure and function
of neuronal circuits [17,25,26] and are thought to partici-
pate in the generation of sex differences in neuroendo-
crine regulation, behavior and cognition. In addition, sex
differences in astrocytes are relevant under pathological
conditions. Numerous neurological and psychiatric disor-
ders, including Parkinson’s disease, Alzheimer’s disease,
Huntington’s disease, multiple sclerosis, traumatic brain
injury, stroke, autism, schizophrenia, depression, anxiety
disorders, eating disorders and peripheral neuropathy,
show sex differences in incidence, age of onset, sympto-
matology and outcome [27-31]. It is plausible that sex
differences in astrocytes might be involved in the genera-
tion of sex differences in the manifestation of brain
pathological alterations. In this regard, previous studies
have shown that cortical astrocytes from male mice are
less resistant than those from female mice to oxygen-
glucose deprivation [32]. This sex difference may be due
to different activity of the enzyme aromatase, which con-
verts testosterone into estradiol; aromatase activity is
higher in cortical female astrocytes than in cortical male
astrocytes [32]. Since aromatase activity is neuroprotec-
tive [33,34], the sexually dimorphic activity of the enzyme
in astrocytes may contribute to protect not only these
cells but also other CNS cell types, including neurons,
from damage.
Furthermore, astrocytes express other enzymes
involved in steroid synthesis and metabolism [35] and
release a variety of neuroprotective steroids, such as
pregnenolone, progesterone and its reduced metabolites,
dihydroprogesterone and tetrahydroprogesterone [36-42],
which may influence the outcome of neurodegenerative
diseases. In addition, astrocytes express steroidogenic
acute regulatory protein (StAR) and translocator protein
of 18 kDa (TSPO, previously known as peripheral benzo-
diazepine receptor) [43-45]. These proteins are involved
in the first step of steroidogenesis: the conversion of cho-
lesterol into pregnenolone by the enzyme P450scc. This
step is highly regulated by the activity of several proteins,
such StAR and TSPO, which facilitate the transport of
cholesterol through the hydrophilic space located
between the outer and inner mitochondrial membranes,
where P450scc is located [45,46].
While the responses of astrocytes to pathological con-
ditions are well documented, the possible existence of
sex differences in these responses has received less atten-
tion. Therefore, in this study, we have assessed whether
cortical astrocytes derived from male and female mice
have a different reaction to an inflammatory challenge
induced by LPS and whether this is associated with dif-
ferences in the expression of two main steroidogenic
regulators: StAR and TSPO. We have assessed the
expression of IL6, TNFa, IL1b and IP10. These mole-
cules were selected because their expression is altered in
the CNS under different pathological conditions, includ-
ing Alzheimer’s disease, Parkinson’s disease, multiple
sclerosis and traumatic brain injury [7]. We have also
explored whether the perinatal peak of androgens, which
participate in the sex differentiation of the CNS in
rodents [47], may influence the subsequent inflammatory
response of astrocytes to LPS. Our results indicate that
cortical primary astrocytes derived from male and female
mice pups show different expression of inflammatory
markers in response to LPS. This difference is associated
with increased expression of TSPO in female astrocytes
exposed to LPS. In addition, our findings suggest that
perinatal testosterone might be involved in the sexually
dimorphic inflammatory response of astrocytes.
Results
Astrocytes from males and females expressed different
mRNA levels of IL6, IP10, TNFa and IL1b after LPS
exposure
The mRNA levels of IL6, IP10, TNFa and IL1b were
first assessed in astrocytes from cultures not treated
with LPS. The results indicate that, under basal condi-
tions, cultures obtained from postnatal day 1 (PND1)
male and female pups expressed similar mRNA levels of
these cytokines (Figure 1).
LPS treatment increased the mRNA levels of IL6, IP10,
TNFa and IL1b in the cultures from both male and
female mice. However, the increase in mRNA levels of
IL6, TNFa and IL1b was significantly higher in the cul-
tures obtained from male pups. In contrast, the increase
in IP10 mRNA levels was higher in the cultures obtained
from females (Figure 2).
Astrocytes from control and androgenized females
expressed different mRNA levels of IL6, IP10, TNFa and
IL1b after LPS exposure
To explore the basis of the sex differences detected in
the previous experiment, we obtained astrocyte cultures
from females treated 24 hours earlier, on PND0, with
testosterone propionate and from control females
injected on PND0 with vehicle. No significant differ-
ences in the levels of IL6, IP10, TNFa and IL1b were
detected under basal conditions (Figure 3).
LPS treatment increased the mRNA levels of IL6,
IP10, TNFa and IL1b in all cultures. However, the
increase in mRNA levels of IL6, TNFa and IL1b was
higher in the cultures obtained from androgenized
females, whereas the increase in IP10 mRNA levels was
higher in the cultures obtained from control females
(Figure 4).
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Astrocytes from males and females expressed similar
mRNA levels of TLR4 under basal conditions and after
LPS exposure
To determine whether the sexually dimorphic response
to LPS was due to different expression levels of the LPS
receptor TLR4 in male and female astrocytes, we mea-
sured the mRNA levels of TLR4 in control and LPS-
treated astrocyte cultures. No significant differences
were detected in the basal mRNA levels of TLR4
between the cultures derived from male and female
pups. In addition, TLR4 mRNA levels were not signifi-
cantly affected by treatment with LPS (Figure 5).
Astrocytes from males and females showed different
regulation of TSPO mRNA levels after LPS exposure
To determine whether the sex differences observed in the
response of IL6, IP10, TNFa and IL1b mRNA levels to
LPS were associated with sex differences in the expres-
sion of steroidogenic proteins, we assessed the mRNA
levels of two proteins involved in cholesterol transport to
the mitochondria: TSPO and StAR. No significant differ-
ences were detected in the mRNA levels of TSPO and
StAR between cultures from males and females under
basal conditions. However, LPS increased the mRNA
levels of TSPO in the cultures from females, but not in
the cultures from males. LPS did not affect StAR mRNA
levels (Figure 6).
Discussion
In this study, we have assessed the expression of IL6, IP10,
TNFa and IL1b by cultured astrocytes derived from the
cerebral cortices of neonatal male and female mice. The
mRNA levels of these inflammatory markers increased in
both male and female astrocytes after incubation with
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Figure 1 Male and female astrocytes express similar mRNA levels of interleukin 6, IFN-inducible protein 10, TNFa and interleukin 1b.
mRNA levels of interleukin 6 (IL6), IFN-inducible protein 10 (IP10), TNFa and interleukin 1b (IL1b) in cortical astrocyte cultures from male and
female mouse pups under basal conditions are shown. Data are means ± standard errors of the mean (SEM) and are expressed as percentages
of female values. No statistically significant differences were detected.
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LPS. These findings are in agreement with previous stu-
dies showing that LPS induces an inflammatory response
in cultured astrocytes [5,12,48]. However, our present
results indicate that male and female astrocytes differ in
the characteristics of their inflammatory response. In
response to LPS, male astrocytes showed enhanced
expression of IL6, TNFa and IL1b, while female astrocytes
showed enhanced expression of IP10. In contrast, under
basal unstimulated conditions, astrocytes from males and
females showed similar mRNA levels of IL6, IP10, TNFa
and IL1b. This suggests that it is the response of astrocytes
to LPS that is sexually dimorphic, not the mechanisms
that regulate the basal expression of IL6, TNFa, IL1b and
IP10.
The inflammatory response to LPS is mediated by
TLR4, a member of the IL1 receptor/TLR superfamily
that is expressed by astrocytes [8-12]. Our findings
indicate that TLR4 mRNA levels are not significantly dif-
ferent between male and female astrocytes both under
resting conditions and after LPS treatment, suggesting
that the sex difference in the inflammatory response of
astrocytes is not mediated by different expression of LPS
receptors. However, we cannot exclude differences in
TLR4 signaling between male and female astrocytes as a
mediating factor}.
Sex differences in the manifestation of several neurode-
generative diseases are associated with differences in
local steroid levels in the CNS [49,50]. Astrocytes express
proteins such as TSPO that are involved in the transport
of cholesterol from the outer to the inner mitochondrial
membrane, where P450scc, the first enzyme of the steroi-
dogenic pathway, is located [35,51]. Therefore, astrocytes
can convert cholesterol in pregnenolone by the enzyme
P450scc. In addition, rodent astrocytes express all the
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Figure 2 Male and female astrocytes show a different response to LPS. mRNA levels of IL6, IP10, TNFa and IL1b in lipopolysaccharide (LPS)-
treated cortical astrocyte cultures from male and female mouse pups are shown. Data are means ± SEM and are expressed as percentages of
controls (red line indicates astrocytes cultured with control medium without LPS). **P < 0.01 and ***P < 0.001, indicating significant differences
compared with female values. +P < 0.05 and +++P < 0.001, indicating significant differences compared with cultures not treated with LPS.
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steroidogenic enzymes necessary to metabolize pregne-
nolone in other steroids, such as progesterone and estra-
diol [35]. Since some of the steroids derived from
pregnenolone have anti-inflammatory properties and
reduce astrogliosis [52-55], and since TSPO expression is
increased after different forms of neural injury [56-58],
we examined whether LPS could induce changes in
TSPO expression in astrocytes. Previous studies have
shown that TSPO is involved in the control of reactive
gliosis [59,60] and regulates several mitochondrial func-
tions, including the control of apoptosis [61,62], which
may also affect the inflammatory response. Our findings
indicate that LPS increases the levels of TSPO in cultured
astrocytes derived from female mice, but not in astrocyte
cultures derived from male mice. However, the mRNA
levels of TSPO were not different between female astro-
cytes stimulated with LPS and male astrocytes under
basal and LPS-stimulated conditions. Therefore, it is
unclear whether the different responses of TSPO to LPS
between male and female astrocytes are sufficient to
explain the sexually dimorphic inflammatory responses
of these cells.
We also analyzed the effect of LPS on the expression
of StAR, another molecule involved in the transport of
cholesterol to the mitochondria [44,45]. In the brain in
vivo, StAR is expressed in specific populations of
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Figure 3 Astrocytes from control and androgenized females express similar mRNA levels of IL6, IP10, TNFa and IL1b. mRNA levels of
IL6, IP10, TNFa and IL1b in cortical astrocyte cultures under basal conditions are shown. Cultures were prepared from postnatal day 1 (PND1)
female mouse pups that were injected on PND0 with vehicle (Female-Oil) or testosterone propionate (Female-TP). Data are means ± SEM and
are expressed as percentages of female oil values. No statistically significant differences were detected.
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astrocytes and neurons, although most cells expressing
the protein are neurons [45,63]. As for TSPO, previous
studies have shown that StAR expression is increased in
the CNS after injury [63,64]. However, in contrast to
TSPO, LPS did not induce a change in the expression of
StAR mRNA in astrocytes. In addition, we did not
detect a difference in StAR expression between male
and female astrocytes. However, we cannot exclude the
possibility of differences in StAR activity, which is regu-
lated by posttranslational modifications of the protein
[45].
Sex differences in astrocytes can result from direct sex
chromosome differences in these cells and/or from dif-
ferent exposure to sex steroids during development [65].
Previous in vivo studies have shown that perinatal
actions of androgens are involved in the generation of
sex differences in the expression of glial fibrillary acidic
protein and in the differentiation and number of astro-
cytes in different brain regions [13,20,23,66]. Our find-
ings indicate that astrocyte cultures derived from female
pups that were androgenized on PD0 show a response
to LPS similar to that of astrocyte cultures derived from
male pups. Thus, LPS induced an increase in the mRNA
levels of IL6, TNFa and IL1b in the cultures obtained
from males and androgenized females compared to con-
trol females. In contrast, LPS induced an increase in
IP10 mRNA levels in the cultures obtained from control
females compared to the cultures obtained from males
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Figure 4 Astrocytes from control and androgenized females show a different response to LPS. mRNA levels of IL6, IP10, TNFa and IL1b in
LPS-treated cortical astrocyte cultures from female mouse pups injected with oil (Oil+LPS) and from female mouse pups treated with
testosterone propionate (TP+LPS). Data are means ± SEM and are expressed as percentages of control values (red line indicates astrocytes
cultured with control medium without LPS). ***P < 0.001, indicating significant differences compared with values of female mouse pups treated
with oil. +++P < 0.001, indicating significant differences compared with cultures not treated with LPS.
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and androgenized females. Therefore, it seems that the
action of testosterone on astrocytes on PD0 is able to
produce modifications in these cells that are maintained
even after their extraction from the brain and their
regrowth in vitro.
Our findings showing sex differences in the inflamma-
tory response of astrocytes are consistent with previous
observations indicating that female astrocytes are more
resistant than male astrocytes to oxygen-glucose depri-
vation and oxidant-induced cell death [32,67]. If transla-
table to in vivo conditions, the different in vitro
inflammatory responses of male and female astrocytes
detected in this study could contribute to sex differences
in the manifestation of neurodegenerative diseases. For
instance, different expression of IP10 between male and
female astrocytes in vivo could result, in sex differences
in the recruitment of T lymphocytes, natural killer cells
and monocytes into the CNS [68,69]. Sex differences in
the expression of IL1b by astrocytes in vivo could result
in sex differences in neuronal injury [70] and in the
remyelination of multiple sclerosis lesions [71].
Enhanced IL6 production by male astrocytes could
result in sex differences in the outcome of acute and
chronic pathological conditions, since astrocyte-driven
production of IL6 in vivo increases chronic inflamma-
tory damage [72] but protects the CNS against acute
focal injury [73-75]. Finally, different production of
TNFa by male and female astrocytes could result in sex
differences in microglial reactivity [76], dysfunction of
the blood-brain barrier [77] and the survival of oligo-
dendrocyte precursors [78,79]. Therefore, further studies
should explore the functional consequences of the dif-
ferent inflammatory responses of male and female astro-
cytes and whether this sexually dimorphic response
affects astrocytes’ survival, activation, proliferation and
ability to protect neurons and oligodendrocytes under
pathological conditions.
Conclusions
In summary, our findings indicate that primary cortical
astrocytes in mice respond differently to an inflamma-
tory challenge, depending on whether they are obtained
from males or females. In addition, primary astrocytes
derived from perinatally androgenized females respond
to inflammatory challenges in the same way that pri-
mary astrocytes derived from males do, suggesting that
perinatal testosterone programs astrocytes for a different
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Figure 5 Astrocytes from males and females express similar
levels of TLR4. mRNA levels of Toll-like receptor 4 (TLR4) in control
and LPS-treated cortical astrocyte cultures from female and male
mouse pups. Data are means ± SEM and are expressed as
percentages of control female astrocytes.
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Figure 6 Male and female astrocytes show a different regulation of TSPO levels after LPS exposure. mRNA levels of translocator protein
18 kDa (TSPO) and steroidogenic acute regulatory protein (StAR) in control and LPS-treated cortical astrocyte cultures from female and male
mouse pups. Data are means ± SEM and are expressed as percentages of control female astrocytes. *P < 0.05, indicating significant difference
compared with control female values.
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response to pathological conditions. These sex differ-
ences with regard to astrocytes may be relevant to the
generation of sex differences in brain pathology.
Methods
Animals and in vivo treatments
CD1 mice dams from the Instituto Cajal animal colony
were kept on a 12-hour light-dark schedule and received
food and water ad libitum until birth. Male and female
pups were distinguished by a larger genital papilla and
longer anogenital distance in male pups than in female
pups. Experimental procedures were approved by our
Institutional Animal Use and Care Committee (Spanish
National Research Council Animal Experimentation
Committee). Special care was taken to minimize suffering
and to reduce the number of animals used to the mini-
mum required for statistical accuracy.
In a first set of experiments, PND1 male and female
pups were used to obtain cortical astrocyte cultures. In a
second set of experiments, female pups were injected at
birth (PND0) with 50 μL of corn oil (vehicle) or 100 μg
of testosterone propionate (diluted 2 mg/mL; Fluka Che-
mie, Buchs, Switzerland). Cortical astrocyte cultures were
obtained from these females on PND1, 24 hours after the
administration of testosterone propionate or vehicle. The
subsequent processing was the same in both sets of
experiments.
Cortical astrocyte primary cultures and in vitro treatments
Astrocytes were cultured from PND1 male and CD1
female mice pups separately. The brain was extracted, the
meninges were removed and the entire neocortex was iso-
lated under a dissecting microscope. Next, the cortex was
dissociated mechanically, washed twice in Hank’s balanced
salt solution (Invitrogen, Paisley, UK) and filtered through
a 40-μm nylon cell strainer into phenol red-free DMEM-
F12 (Invitrogen, Paisley, UK) containing 10% fetal bovine
serum (FBS; Invitrogen) and penicillin-streptomycin (Invi-
trogen). After centrifugation at 1,000 rpm for 5 minutes,
cells were resuspended and cultured in 75-cm2 tissue cul-
ture flasks at 37°C and 5% CO2. The medium was changed
after one day in vitro and subsequently two times per
week until the cells reached confluence. Next, enriched
astrocyte cultures were obtained after overnight shaking at
37°C and 280 rpm on a tabletop shaker (Thermo Forma,
Marietta, OH, USA) to minimize oligodendrocyte and
microglia contamination. Astrocytes were removed from
the flasks by incubation with 0.5% trypsin (type II-S;
Sigma-Aldrich, St Louis, MO, USA) and 0.04% ethylene-
diaminetetraacetic acid (Sigma-Aldrich). Trypsinization
was stopped with DMEM-F12 medium with FBS, the cell
suspension was centrifuged and the pellet was resus-
pended and plated onto poly-L-lysine-coated six-well
plates in serum-free medium and used within 24 hours.
One day after plating astrocytes were treated for 5 hours
with medium containing LPS (500 ng/mL LPS, Escherichia
coli 026:B6; Sigma-Aldrich) or with control medium with-
out LPS. The dose of LPS was based on that used in a
previous study [5].
Quantitative real-time polymerase chain reaction
After 5 hours of treatment with LPS, culture medium was
removed and cells were lysed. Total RNA was extracted
using the illustra RNAspin Mini RNA Isolation Kit (GE
Healthcare, Buckinghamshire, UK) to assess the mRNA
expression levels of IL6, IP10, TNFa, IL1b, TLR4, StAR
and TSPO.
First-strand cDNA was prepared from 1 μg of RNA
using M-MLV Reverse Transcriptase (Promega, Madi-
son, WI, USA) according to the manufacturer’s protocol.
After reverse transcription, the cDNA was diluted 1:4
for the unknown gene and 1:100 for the endogenous
control, and 5 μL of these cDNA solutions were ampli-
fied by real-time PCR in a 15 μL voulme reaction using
SYBR Green PCR MasterMix (Applied Biosystems,
Foster City, CA, USA) or TaqMan Universal PCR Mas-
terMix (Applied Biosystems) using the ABI Prism 7500
Sequence Detection System (Applied Biosystems) with
conventional Applied Biosystems cycling parameters
(40 cycles of changing temperatures, first at 95°C for 15
seconds and then at 60°C for 1 minute). The primer
sequences were designed using Primer Express software
(Applied Biosystems) and are shown in Table 1.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was selected as a control housekeeping gene. The
GAPDH TaqMan probes and primers used were the
Assays-on-Demand Gene Expression Products (Applied
Biosystems). After amplification, a denaturing curve was
performed to ensure the presence of unique amplification
products.
To visualize and sequence the PCR products, each
amplification product was electrophoresed on 2% (wt/
vol) ethidium bromide-stained agarose gel. Next, bands
were excised and cDNA was purified using the QIAquick
PCR Purification Kit (Qiagen Iberia, Madrid, Spain).
Samples were sequenced (Automatic Sequencing Center,
CSIC, Madrid, Spain) with the corresponding forward or
reverse primer. The obtained sequence was aligned with
the expected sequence of each transcript obtained from
GenBank. All reactions were performed in duplicate, and
the quantities of target gene expression were normalized
to the corresponding GAPDH expression in test samples
and plotted.
Statistical analysis
Statistical significance was assessed by performing an
unpaired t-test for the one-to-one comparisons and
one-way analysis of variance followed by the Tukey post
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hoc test for comparisons with more than two experi-
mental groups. GraphPad Prism 5 software (GraphPad
Software, San Diego, CA, USA) was used for the analy-
sis. The significance level was set at P < 0.05. Data
shown in the figures are the results of three to seven
independent experiments and data are presented as the
mean ± standard error of the mean.
Abbreviations
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